INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2019

Higher serum TMAO levels were linked to first-ever acute ischemic stroke and greater stroke severity in Chinese patients.

A case-control study evaluated serum TMAO levels in 255 consecutive patients with first-ever acute ischemic stroke and 255 age- and gender-matched healthy controls. Median TMAO levels were higher in stroke patients (5.8 μM; IQR, 3.3-10.0) than in controls (3.9 μM; IQR, 2.6-6.1). Patients with moderate-to-high stroke severity (NIHSS > 6) had higher median TMAO than minor stroke patients (9.1 μM vs. 4.1 μM, P<0.001). Each 1 μM increase in TMAO was associated with a 22% increased multivariable-adjusted risk of moderate-to-high stroke (OR = 1.22; 95% CI: 1.08-1.32; P<0.001).

Shows an association, not proof of cause and effect.

Study type
Case-control study
Who was studied
255 patients with first-ever acute ischemic stroke and 255 matched healthy controls in China
What was measured
Serum TMAO levels and stroke severity based on the NIH Stroke Scale (NIHSS)

THE PAPER

Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke.

Rexidamu M, Li H, Jin H, Huang J. Biosci Rep, 2019.

PubMed 31142624 ↗DOI 10.1161/jaha.117.006347 ↗

Heart & arteriesGut & microbiomeBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.